Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Timing tax-loss harvesting with index funds can maximize tax efficiency in retirement accounts while maintaining asset allocation and growth potential.
17,783 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
A pair of geopolitical developments is reviving appetite for riskier assets and triggering a chip-stock rally back fu...
As AI demand drives Marvell Technology higher, investors debate whether the stock can reach $300 this summer. Here’s ...
Tech stock volatility puts Anthropic's planned IPO at risk as market conditions sour for high-growth debuts. A confid...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
Medicare will cover GLP-1 weight-loss drugs for eligible beneficiaries beginning this week, a policy shift that could...
Nvidia’s shares lag the broader chip rally even as demand for AI accelerates, prompting questions about earnings timi...
A Chinese regulator warned of a security backdoor in Anthropic's Claude Code, signaling tightened AI-tool oversight a...
In a striking move, trump’s crypto disclosure exposes how policy signals and private crypto stakes collide at the hig...
Micron Technology fell about 8% in Wednesday trading as investors priced in rising competition from Chinese memory ma...
SpaceX fans and market watchers saw the stock quietly drift lower toward the mid-$120s. This piece breaks down why th...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...